SBC Medical Joins Russell 3000 Index

By Tamara Parker • Monday, June 30 15:31 • Permanent Link

SBC Medical Group Holdings Incorporated (NASDAQ: SBC) has announced that it has been added to the Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell Indexes reconstitution. Membership in the Russell 3000® Index means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes.

As of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US Indexes, which belong to FTSE Russell, the global index provider. This move is significant as Russell Indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies.

Fiona Bassett, CEO of FTSE Russell, commented on the importance of recalibrating the suite of Russell US Indexes to ensure they accurately represent the market. The transition to a semi-annual reconstitution frequency from 2026 will ensure the indexes continue to represent the market and maintain the purpose of the index as a portfolio benchmark.

SBC Medical, headquartered in Irvine, California, and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The company is primarily focused on providing comprehensive management services to franchisee clinics, including advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement, the provision of cosmetic products to franchisee clinics for resale, licensure of the use of medical technologies, trademark and brand use, IT software solutions, management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

For more information on the Russell 3000® Index and the Russell Indexes reconstitution, interested individuals can visit the “Russell Reconstitution” section on the FTSE Russell website. Following these announcements, the company's shares moved -0.43%, and are now trading at a price of $4.62. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.